E-nitiate Biopharmaceuticals
Hangzhou
About E-nitiate Biopharmaceuticals
E-nitiate Biopharmaceuticals is committed to the development of innovative drugs for autoimmune diseases, through independent research and development, and strategic collaborations, to address unmet medical needs and to improve the quality of human life.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $45.5M
- Funding stage: Early Stage Venture
- Last round: Series B (Sep 2025)
- Website: enitiatebio.comen.php
- Phone: 0571-86229868
Industries & Categories
Biopharma, Biotechnology, Health Care, Hospital
Canonical: https://fsome.com/organization/e-nitiate-biopharmaceuticals-74509 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.